Who's In And Who's Out In China's Largest Reimbursed Drug List Revamp?

Companies Hope Volumes Will Offset Sharply Lower Prices

Some manufacturers willing to offer global-low prices in exchange for reimbursement coverage in the world's second-largest pharma market.

US dollar and Yuan China which its are 2 biggest countries for economic growth.Now America and China announce tariff tax policy to make conflict.
DEEP PRICE CUTS TO GAIN REIMBURSEMENT IN CHINA LIST REVAMP • Source: Shutterstock

More from China

More from Focus On Asia